综述

血管内皮生长因子对青光眼的视神经保护机制的研究进展

展开
  • 上海交通大学医学院附属瑞金医院眼科,上海 200025

收稿日期: 2021-01-20

  网络出版日期: 2022-06-28

本文引用格式

孙俊, 余欢, 黄守约 . 血管内皮生长因子对青光眼的视神经保护机制的研究进展[J]. 诊断学理论与实践, 2021 , 20(03) : 290 -293 . DOI: 10.16150/j.1671-2870.2021.03.011

参考文献

[1] Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development[J]. Cell, 2019, 176(6):1248-1264.
[2] Song P, Wang J, Bucan K, et al. National and subnatio-nal prevalence and burden of glaucoma in China: a systematic analysis[J]. J Glob Health, 2017, 7(2):020705.
[3] Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review[J]. JAMA, 2014, 311(18):1901-1911.
[4] Ferrara N, Adamis AP. Ten years of anti-vascular endothelial growth factor therapy[J]. Nat Rev Drug Discov, 2016, 15(6):385-403.
[5] Melincovici CS, Boşca AB, Şuşman S, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis[J]. Rom J Morphol Embryol, 2018, 59(2):455-467.
[6] Alkharsah KR. VEGF upregulation in viral infections and its possible therapeutic implications[J]. Int J Mol Sci, 2018, 19(6):1642.
[7] Chen R, Lee C, Lin X, et al. Novel function of VEGF-B as an antioxidant and therapeutic implications[J]. Pharmacol Res, 2019, 143:33-39.
[8] van Bergen T, Etienne I, Cunningham F, et al. The role of placental growth factor(PlGF) and its receptor system in retinal vascular diseases[J]. Prog Retin Eye Res, 2019, 69:116-136.
[9] Wang J, Huang Y, Zhang J, et al. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis[J]. Clin Chim Acta, 2016, 461:165-171.
[10] Tian YI, Zhang X, Torrejon K, et al. A bioengineering approach to Schlemm′s canal-like stem cell differentiation for in vitro glaucoma drug screening[J]. Acta Biomater, 2020, 105:203-213.
[11] Stein JD, Khawaja AP, Weizer JS. Glaucoma in adults-screening, diagnosis, and management: a review[J]. JAMA, 2021, 325(2):164-174.
[12] 汤加, 陈有信. 血管内皮生长因子的神经保护作用[J]. 中华实验眼科杂志, 2020, 38(1): 64-67.
[13] Lange C, Storkebaum E, de Almodóvar CR, et al. Vascular endothelial growth factor: a neurovascular target in neurological diseases[J]. Nat Rev Neurol, 2016, 12(8):439-454.
[14] Cattin AL, Burden JJ, Van Emmenis L, et al. Macrophage-induced blood vessels guide schwann cell-mediated regeneration of peripheral nerves[J]. Cell, 2015, 162(5):1127-1139.
[15] Po$\grave{\text z}$arowska D, Po$\grave{\text z}$arowski P, The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy[J]. Cent Eur J Immunol, 2016, 41(3):311-316.
[16] Sun C, Zhang H, Jiang J, et al. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy[J]. Int Ophthalmol, 2020, 40(2):467-475.
[17] 张水华, 曲毅. 血管内皮生长因子B对小鼠视神经保护作用的研究[J]. 中华眼科杂志, 2009, 45(1):38-42.
[18] Shen J, Xiao R, Bair J, et al. Novel engineered, membrane-localized variants of vascular endothelial growth factor (VEGF) protect retinal ganglion cells: a proof-of-concept study[J]. Cell Death Dis, 2018, 9(10):1018.
[19] Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury[J]. Am J Pathol, 2007, 171(1):53-67.
[20] Fahy ET, Chrysostomou V, Crowston JG. Mini-review: impaired axonal transport and glaucoma[J]. Curr Eye Res, 2016, 41(3):273-283.
[21] 朱轶冰, 陆佩华, 盛祖杭. AD发病机制的新探索:轴浆运输障碍假说[J]. 生理科学进展, 2008, 39(1):5-9.
[22] 党鸿辛, 辛晓蓉. 青光眼视神经损伤机制的研究进展[J]. 眼科新进展, 2016, 36(7):680-683.
[23] Foxton R, Osborne A, Martin KR, et al. Distal retinal ganglion cell axon transport loss and activation of p38 MAPK stress pathway following VEGF-A antagonism[J]. Cell Death Dis, 2016, 7(5):e2212.
[24] Yang P, Sun X, Kou ZW, et al. VEGF axonal transport dependent on kinesin-1B and microtubules dynamics[J]. Front Mol Neurosci, 2017, 10:424.
[25] Dapper JD, Crish SD, Pang IH, et al. Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy[J]. Neurobiol Dis, 2013, 59:26-37.
[26] Tsai T, Grotegut P, Reinehr S, et al. Role of heat shock proteins in glaucoma[J]. Int J Mol Sci, 2019, 20(20):5160.
[27] Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling[J]. Nat Rev Mol Cell Biol, 2016, 17(10):611-625.
[28] Foxton RH, Finkelstein A, Vijay S, et al. VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma[J]. Am J Pathol, 2013, 182(4):1379-1390.
[29] Almasieh M, Wilson AM, Morquette B, et al. The mole-cular basis of retinal ganglion cell death in glaucoma[J]. Prog Retin Eye Res, 2012, 31(2):152-181.
[30] Lawler T, Liu Y, Christensen K, et al. Dietary antioxidants, macular pigment, and glaucomatous neurodegene-ration: a review of the evidence[J]. Nutrients, 2019, 1(5):1002.
[31] Li Y, Zhang F, Nagai N, et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats[J]. J Clin Invest, 2008, 118(3):913-923.
[32] Shukla S, Saxena S, Singh BK, et al. BH3-only protein BIM: an emerging target in chemotherapy[J]. Eur J Cell Biol, 2017, 96(8):728-738.
[33] Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases[J]. Prog Retin Eye Res, 2015, 49:67-81.
[34] Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease[J]. Annu Rev Vis Sci, 2018, 4:45-77.
[35] Galán-Ganga M, García-YagüeáJ, Lastres-Becker I. Role of MSK1 in the induction of NF-κB by the chemokine CX3CL1 in microglial cells[J]. Cell Mol Neurobiol, 2019, 39(3):331-340.
[36] Perbal A. 8th international workshop on the CCN family of genes-Nice November 3-8, 2015[J]. J Cell Commun Signal, 2016, 10(1):87-101.
[37] Rothhammer V, Borucki DM, Tjon EC, et al. Microglial control of astrocytes in response to microbial metabolites[J]. Nature, 2018, 557(7707):724-728.
[38] Hoguet A, Chen PP, Junk AK, et al. The effect of anti-vascular endothelial growth factor agents on intraocular pressure and glaucoma: a report by the American Academy of Ophthalmology[J]. Ophthalmology, 2019, 126(4):611-622.
文章导航

/